Literature DB >> 1718013

Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.

M Barrios1, J M Baeyens.   

Abstract

The effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine were evaluated. Verapamil (10-80 mg/kg), diltiazem (20-120 mg/kg) and nicardipine (20-160 mg/kg), when administered subcutaneously, produced a dose-dependent reduction in forepaw tremor and weight loss during the abstinence reaction; jumping was also reduced by all three drugs, although the effect was not statistically significant in the case of nicardipine. By contrast, the calcium agonist Bay K 8644 (0.5-2 mg/kg, SC) increased forepaw tremor and weight loss, although this latter effect did not reach statistical significance. The effects of the calcium channel active drugs on the rotarod test were also explored, no correlation appearing with the results observed in abstinence (except for the jumping response), which suggests that the withdrawal results are not influenced by motor incoordination or unspecific CNS depression. These findings suggest that L-type calcium channels probably play an important role in withdrawal after acute morphine dependence. Taken together with other observations in chronic models, these results show that calcium channels are similarly involved in morphine abstinence after acute and chronic dependence, in contrast to the differences in the content and uptake of neuronal calcium induced by morphine under both conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718013     DOI: 10.1007/bf02246042

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

Review 1.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

2.  Cellular site of opiate dependence.

Authors:  H O Collier
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

Review 3.  Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction.

Authors:  G Zernig
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

4.  The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and -dependent mice.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

5.  Opiate tolerance and dependence induced in vitro in single myenteric neurones.

Authors:  R A North; P J Karras
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

6.  Dose-dependent and stereoselective antagonism by diltiazem of naloxone-precipitated morphine abstinence after acute morphine-dependence in vivo and in vitro.

Authors:  G Caro; M Barrios; J M Baeyens
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

7.  Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade.

Authors:  A Salvador; E del Pozo; R Carlos; J M Baeyens
Journal:  Br J Anaesth       Date:  1988-04       Impact factor: 9.166

8.  Calcium channel antagonists decrease the ethanol withdrawal syndrome.

Authors:  H J Little; S J Dolin; M J Halsey
Journal:  Life Sci       Date:  1986-12-01       Impact factor: 5.037

9.  Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence.

Authors:  V Ramkumar; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

10.  Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.

Authors:  L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

View more
  10 in total

Review 1.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

Review 2.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

3.  Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.

Authors:  S Tokuyama; I K Ho
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.

Authors:  Nichole C Sanders; Michael J Mancino; W Brooks Gentry; J Benjamin Guise; Warren K Bickel; Jeff Thostenson; Alison H Oliveto
Journal:  Exp Clin Psychopharmacol       Date:  2013-07-15       Impact factor: 3.157

5.  Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.

Authors:  Alison Oliveto; Michael Mancino; Nichole Sanders; Christopher Cargile; J Benjamin Guise; Warren Bickel; W Brooks Gentry
Journal:  Eur J Pharmacol       Date:  2013-03-21       Impact factor: 4.432

6.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

7.  Alleviation of Morphine Withdrawal Signs but Not Tolerance by the Essential Oil of Kelussia odoratissima Mozaff.

Authors:  Mohammed Rabbani; Seyed Ebrahim Sajjadi; Azadeh Izadi
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

8.  Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial.

Authors:  Nihit Kumar; Michael J Mancino; Jeff D Thostenson; Janette McGaugh; Alison H Oliveto
Journal:  Subst Abuse       Date:  2020-11-23

9.  The effect of nimodipine on memory loss following naloxone-induced morphine withdrawal in object recognition.

Authors:  G Vaseghi; V Hajhashemi; M Rabbani
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec

10.  Role of calcium in morphine dependence and naloxone-precipitated withdrawal in mice.

Authors:  Vikas Seth; Prerna Upadhyaya; Vijay Moghe; Mushtaq Ahmad
Journal:  J Exp Pharmacol       Date:  2011-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.